nach oben

Angiogenesis

Erschienen in:

24.07.2023 | Original Paper

FOXO1 promotes endothelial cell elongation and angiogenesis by up-regulating the phosphorylation of myosin light chain 2

verfasst von: Kiyomi Tsuji-Tamura, Minetaro Ogawa

Erschienen in: Angiogenesis | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

The forkhead box O1 (FOXO1) is an important transcription factor related to proliferation, metabolism, and homeostasis, while the major phenotype of FOXO1-null mice is abnormal vascular morphology, such as vessel enlargement and dilation. In in vitro mouse embryonic stem cell (ESC)-differentiation system, Foxo1^−/− vascular endothelial cells (ECs) fail to elongate, and mimic the abnormalities of FOXO1-deficiency in vivo. Here, we identified the PPP1R14C gene as the FOXO1 target genes responsible for elongating using transcriptome analyses in ESC-derived ECs (ESC-ECs), and found that the FOXO1-PPP1R14C-myosin light chain 2 (MLC2) axis is required for EC elongation during angiogenesis. MLC2 is phosphorylated by MLC kinase (MLCK) and dephosphorylated by MLC phosphatase (MLCP). PPP1R14C is an inhibitor of PP1, the catalytic subunit of MLCP. The abnormal morphology of Foxo1^−/− ESC-ECs was associated with low level of PPP1R14C and loss of MLC2 phosphorylation, which were reversed by PPP1R14C-introduction. Knockdown of either FOXO1 or PPP1R14C suppressed vascular cord formation and reduced MLC2 phosphorylation in human ECs (HUVECs). The mouse and human PPP1R14C locus possesses an enhancer element containing conserved FOXO1-binding motifs. In vivo chemical inhibition of MLC2 phosphorylation caused dilated vascular structures in mouse embryos. Furthermore, foxo1 or ppp1r14c-knockdown zebrafish exhibited vascular malformations, which were also restored by PPP1R14C-introduction. Mechanistically, FOXO1 suppressed MLCP activity by up-regulating PPP1R14C expression, thereby promoting MLC2 phosphorylation and EC elongation, which are necessary for vascular development. Given the importance of MLC2 phosphorylation in cell morphogenesis, this study may provide novel insights into the role of FOXO1 in control of angiogenesis.

Nur mit Berechtigung zugänglich

Accili D, Arden KC (2004) FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117:421–426. https://doi.org/10.1016/s0092-8674(04)00452-0CrossRefPubMed

Salih DA, Brunet A (2008) FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr Opin Cell Biol 20:126–136. https://doi.org/10.1016/j.ceb.2008.02.005CrossRefPubMedPubMedCentral

Kim YH, Choi J, Yang MJ et al (2019) A MST1–FOXO1 cascade establishes endothelial tip cell polarity and facilitates sprouting angiogenesis. Nat Commun 10:838. https://doi.org/10.1038/s41467-019-08773-2CrossRefPubMedPubMedCentral

Tsuchiya K, Tanaka J, Shuiqing Y et al (2012) FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis. Cell Metab 15:372–381. https://doi.org/10.1016/j.cmet.2012.01.018CrossRefPubMedPubMedCentral

Benchoula K, Arya A, Parhar IS, Hwa WE (2021) FoxO1 signaling as a therapeutic target for type 2 diabetes and obesity. Eur J Pharmacol 891:173758. https://doi.org/10.1016/j.ejphar.2020.173758CrossRefPubMed

Hornsveld M, Dansen TB, Derksen PW, Burgering BMT (2018) Re-evaluating the role of FOXOs in cancer. Semin Cancer Biol 50:90–100. https://doi.org/10.1016/j.semcancer.2017.11.017CrossRefPubMed

Furuyama T, Kitayama K, Shimoda Y et al (2004) Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J Biol Chem 279:34741–34749. https://doi.org/10.1074/jbc.M314214200CrossRefPubMed

Hosaka T, Biggs WH III, Tieu D et al (2004) Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc Natl Acad Sci USA 101(9):2975–2980. https://doi.org/10.1073/pnas.0400093101CrossRefPubMedPubMedCentral

Sengupta A, Chakraborty S, Paik J et al (2012) FoxO1 is required in endothelial but not myocardial cell lineages during cardiovascular development. Dev Dyn 241:803–813. https://doi.org/10.1002/dvdy.23759CrossRefPubMed

10.

Dharaneeswaran H, Abid MR, Yuan L et al (2014) FOXO1-mediated activation of akt plays a critical role in vascular homeostasis. Circ Res 115:238–251. https://doi.org/10.1161/CIRCRESAHA.115.303227CrossRefPubMedPubMedCentral

11.

Potente M, Urbich C, Sasaki KI et al (2005) Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J Clin Investig 115:2382–2392. https://doi.org/10.1172/JCI23126CrossRefPubMedPubMedCentral

12.

Wilhelm K, Happel K, Eelen G et al (2016) FOXO1 couples metabolic activity and growth state in the vascular endothelium. Nature 529:216–220. https://doi.org/10.1038/nature16498CrossRefPubMedPubMedCentral

13.

Brent MM, Anand R, Marmorstein R (2008) Structural Basis for DNA Recognition by FoxO1 and Its Regulation by Posttranslational Modification. Structure 16:1407–1416. https://doi.org/10.1016/j.str.2008.06.013CrossRefPubMedPubMedCentral

14.

Ren L, Yang J, Wang J et al (2021) The roles of FOXO1 in periodontal homeostasis and disease. J Immunol Res. https://doi.org/10.1155/2021/5557095CrossRefPubMedPubMedCentral

15.

Hirashima M, Kataoka H, Nishikawa S et al (1999) Maturation of embryonic stem cells into endothelial cells in an in vitro model of vasculogenesis. Blood 93:1253–1263CrossRefPubMed

16.

Yamashita J, Itoh H, Hirashima M et al (2000) Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408:92–96. https://doi.org/10.1038/35040568CrossRefPubMed

17.

Matsukawa M, Sakamoto H, Kawasuji M et al (2009) Different roles of Foxo1 and Foxo3 in the control of endothelial cell morphology. Genes Cells 14:1167–1181. https://doi.org/10.1111/j.1365-2443.2009.01343.xCrossRefPubMed

18.

Park S-H, Sakamoto H, Tsuji-Tamura K et al (2009) Foxo1 is essential for in vitro vascular formation from embryonic stem cells. Biochem Biophys Res Commun 390:861–866. https://doi.org/10.1016/j.bbrc.2009.10.063CrossRefPubMed

19.

Tsuji-Tamura K, Ogawa M (2016) Inhibition of the PI3K-Akt and mTORC1 signaling pathways promotes the elongation of vascular endothelial cells. J Cell Sci 129:1165–1178. https://doi.org/10.1242/jcs.178434CrossRefPubMed

20.

Tsuji-Tamura K, Morino-Koga S, Suzuki S, Ogawa M (2021) The canonical smooth muscle cell marker TAGLN is present in endothelial cells and is involved in angiogenesis. J Cell Sci 134:jcs254920. https://doi.org/10.1242/jcs.254920CrossRefPubMed

21.

Tsuji-Tamura K, Ogawa M (2018) Morphology regulation in vascular endothelial cells. Inflamm Regen 38:1–13. https://doi.org/10.1186/s41232-018-0083-8CrossRef

22.

Levayer R, Lecuit T (2012) Biomechanical regulation of contractility: spatial control and dynamics. Trends Cell Biol 22:61–81. https://doi.org/10.1016/j.tcb.2011.10.001CrossRefPubMed

23.

Vicente-Manzanares M, Ma X, Adelstein RS, Horwitz AR (2009) Non-muscle myosin II takes centre stage in cell adhesion and migration. Nat Rev Mol Cell Biol 10:778–790. https://doi.org/10.1038/nrm2786CrossRefPubMedPubMedCentral

24.

Pearson RB, Jakes R, John M et al (1984) Phosphorylation site sequence of smooth muscle myosin light chain (Mr = 20 000). FEBS Lett 168:108–112. https://doi.org/10.1016/0014-5793(84)80216-1CrossRefPubMed

25.

Sitbon YH, Yadav S, Kazmierczak K, Szczesna-Cordary D (2020) Insights into myosin regulatory and essential light chains: a focus on their roles in cardiac and skeletal muscle function, development and disease. J Muscle Res Cell Motil 41:313–327. https://doi.org/10.1007/s10974-019-09517-xCrossRefPubMed

26.

Molinar-Inglis O, Wozniak JM, Grimsey NJ et al (2022) Phosphoproteomic analysis of thrombin- and p38 MAPK-regulated signaling networks in endothelial cells. J Biol Chem 298:101801. https://doi.org/10.1016/j.jbc.2022.101801CrossRefPubMedPubMedCentral

27.

Kunimura K, Miki S, Takashima M, Suzuki JI (2021) S-1-propenylcysteine improves TNF-α-induced vascular endothelial barrier dysfunction by suppressing the GEF-H1/RhoA/Rac pathway. Cell Commun Signal 19:1–14. https://doi.org/10.1186/s12964-020-00692-wCrossRef

28.

Mavria G, Vercoulen Y, Yeo M et al (2006) ERK-MAPK signaling opposes Rho-kinase to promote endothelial cell survival and sprouting during angiogenesis. Cancer Cell 9:33–44. https://doi.org/10.1016/j.ccr.2005.12.021CrossRefPubMed

29.

Abraham S, Yeo M, Montero-Balaguer M et al (2009) VE-cadherin-mediated cell-cell interaction suppresses sprouting via signaling to MLC2 phosphorylation. Curr Biol 19:668–674. https://doi.org/10.1016/j.cub.2009.02.057CrossRefPubMed

30.

Shen Q, Rigor RR, Pivetti CD et al (2010) Myosin light chain kinase in microvascular endothelial barrier function. Cardiovasc Res 87:272–280. https://doi.org/10.1093/cvr/cvq144CrossRefPubMedPubMedCentral

31.

Tsuji-Tamura K, Sato M, Fujita M, Tamura M (2020) The role of PI3K/Akt/mTOR signaling in dose-dependent biphasic effects of glycine on vascular development. Biochem Biophys Res Commun 529:596–602. https://doi.org/10.1016/j.bbrc.2020.06.085CrossRefPubMed

32.

Nakahara M, Tateyama H, Araki M et al (2013) Gene-trap mutagenesis using Mol/MSM-1 embryonic stem cells from MSM/Ms mice. Mamm Genome 24:228–239. https://doi.org/10.1007/s00335-013-9452-4CrossRefPubMed

33.

De Val S, Chi NC, Meadows SM et al (2008) Combinatorial regulation of endothelial gene expression by Ets and forkhead transcription factors. Cell 135:1053–1064. https://doi.org/10.1016/j.cell.2008.10.049CrossRefPubMedPubMedCentral

34.

Kodama H, Niida S, Nishikawa S (1994) Involvement of the c-kit receptor in the adhesion of hematopoietic stem cells to stromal cells. Exp Hematol 22:979–984PubMed

35.

Fukuhara S, Zhang J, Yuge S et al (2014) Visualizing the cell-cycle progression of endothelial cells in zebrafish. Dev Biol 393:10–23. https://doi.org/10.1016/j.ydbio.2014.06.015CrossRefPubMed

36.

Avdesh A, Chen M, Martin-Iverson MT et al (2012) Regular care and maintenance of a Zebrafish (Danio rerio) laboratory: an introduction. J Vis Exp. https://doi.org/10.3791/4196CrossRefPubMedPubMedCentral

37.

Nüsslein-Volhard C, Dahm R (2002) Zebrafish: a practical approach (The Practical Approach Series). Oxford University Press

38.

Matsuyoshi N, Toda K, Horiguchi Y et al (1997) In vivo evidence of the critical role of cadherin-5 in murine vascular integrity. Proc Assoc Am Phys 109:362–371PubMed

39.

Kataoka H, Takakura N, Nishikawa S et al (1997) Expressions of PDGF receptor alpha, c-Kit and Flk1 genes clustering in mouse chromosome 5 define distinct subsets of nascent mesodermal cells. Dev Growth Differ 39(6):729–740CrossRefPubMed

40.

Niwa H, Yamamura K, Miyazaki J (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193–199. https://doi.org/10.1016/0378-1119(91)90434-dCrossRefPubMed

41.

Aoyama H, Ikeda Y, Miyazaki Y et al (2011) Isoform-specific roles of protein phosphatase 1 catalytic subunits in sarcoplasmic reticulum-mediated Ca2 cycling. Cardiovasc Res 89:79–88. https://doi.org/10.1093/cvr/cvq252CrossRefPubMed

42.

Tang ED, Nuñez G, Barr FG, Guan KL (1999) Negative regulation of the forkhead transcription factor FKHR by Akt. J Biol Chem 274(24):16741–16746. https://doi.org/10.1074/jbc.274.24.16741CrossRefPubMed

43.

Carpentier G, Berndt S, Ferratge S et al (2020) Angiogenesis Analyzer for ImageJ—a comparative morphometric analysis of “Endothelial Tube Formation Assay” and “Fibrin Bead Assay.” Sci Rep 10:11568. https://doi.org/10.1038/s41598-020-67289-8CrossRefPubMedPubMedCentral

44.

Guo S, Rena G, Cichy S et al (1999) Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 Promoter activity through a conserved insulin response sequence. J Biol Chem 274:17184–17192. https://doi.org/10.1074/jbc.274.24.17184CrossRefPubMed

45.

Yokomizo T, Dzierzak E (2010) Three-dimensional cartography of hematopoietic clusters in the vasculature of whole mouse embryos. Development 137:3651–3661. https://doi.org/10.1242/dev.051094CrossRefPubMedPubMedCentral

46.

Shoham AB, Malkinson G, Krief S et al (2012) S1P1 inhibits sprouting angiogenesis during vascular development. Development 139:3859–3869. https://doi.org/10.1242/dev.078550CrossRefPubMed

47.

Eto M (2009) Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, C-kinase-activated PP1 Inhibitors. J Biol Chem 284:35273–35277. https://doi.org/10.1074/jbc.R109.059972CrossRefPubMedPubMedCentral

48.

Eto M, Brautigan DL (2012) Endogenous inhibitor proteins that connect Ser/Thr kinases and phosphatases in cell signaling. IUBMB Life 64:732–739CrossRefPubMedPubMedCentral

49.

Matos B, Howl J, Jerónimo C, Fardilha M (2021) Modulation of serine/threonine-protein phosphatase 1 (PP1) complexes: a promising approach in cancer treatment. Drug Discov Today 26:2680–2698. https://doi.org/10.1016/j.drudis.2021.08.001CrossRefPubMed

50.

Tsuji-Tamura K, Ogawa M (2018) Dual inhibition of mTORC1 and mTORC2 perturbs cytoskeletal organization and impairs endothelial cell elongation. Biochem Biophys Res Commun 497:326–331. https://doi.org/10.1016/j.bbrc.2018.02.080CrossRefPubMed

51.

Tsuji-Tamura K, Tamura M (2022) Basic fibroblast growth factor uniquely stimulates quiescent vascular smooth muscle cells and induces proliferation and dedifferentiation. FEBS Lett 596:1686–1699. https://doi.org/10.1002/1873-3468.14345CrossRefPubMed

52.

Karthik S, Djukic T, Kim JD et al (2018) Synergistic interaction of sprouting and intussusceptive angiogenesis during zebrafish caudal vein plexus development. Sci Rep 8:9840. https://doi.org/10.1038/s41598-018-27791-6CrossRefPubMedPubMedCentral

53.

Kniazeva E, Putnam AJ (2009) Endothelial cell traction and ECM density influence both capillary morphogenesis and maintenance in 3-D. Am J Physiol Cell Physiol 297:179–187. https://doi.org/10.1152/ajpcell.00018.2009.-IdentifyingCrossRef

54.

Oikawa T, Suganuma M, Ashino-Fuse H, Shimamura M (1992) Okadaic acid is a potent angiogenesis inducer. Jpn J Cancer Res 83:6–9. https://doi.org/10.1111/j.1349-7006.1992.tb02343.xCrossRefPubMedPubMedCentral

55.

Kim YS, Ahn KH, Kim SY, Jeong JW (2009) Okadaic acid promotes angiogenesis via activation of hypoxia-inducible factor-1. Cancer Lett 276:102–108. https://doi.org/10.1016/j.canlet.2008.10.034CrossRefPubMed

56.

Blum Y, Belting HG, Ellertsdottir E et al (2008) Complex cell rearrangements during intersegmental vessel sprouting and vessel fusion in the zebrafish embryo. Dev Biol 316:312–322. https://doi.org/10.1016/j.ydbio.2008.01.038CrossRefPubMed

57.

Mentzer SJ, Konerding MA (2014) Intussusceptive angiogenesis: Expansion and remodeling of microvascular networks. Angiogenesis 17:499–509. https://doi.org/10.1007/s10456-014-9428-3CrossRefPubMedPubMedCentral

58.

Norton KA, Popel AS (2016) Effects of endothelial cell proliferation and migration rates in a computational model of sprouting angiogenesis. Sci Rep 6:36992. https://doi.org/10.1038/srep36992CrossRefPubMedPubMedCentral

59.

Andrew DJ, Ewald AJ (2010) Morphogenesis of epithelial tubes: Insights into tube formation, elongation, and elaboration. Dev Biol 341:34–55. https://doi.org/10.1016/j.ydbio.2009.09.024CrossRefPubMed

60.

Bryan BA, Dennstedt E, Mitchell DC et al (2010) RhoA/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis. FASEB J 24:3186–3195. https://doi.org/10.1096/fj.09-145102CrossRefPubMedPubMedCentral

61.

Valenti L, Rametta R, Dongiovanni P et al (2008) Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis. Diabetes 57:1355–1362. https://doi.org/10.2337/db07-0714CrossRefPubMed

62.

Ibrahim HA, Zakaria SS, El-Batch MM et al (2022) The value of SIRT1/FOXO1 signaling pathway in early detection of cardiovascular risk in children with β-thalassemia major. Biomedicines 10:2601. https://doi.org/10.3390/biomedicines10102601CrossRefPubMedPubMedCentral

63.

Kaela X, Varberg M, Garretson RO et al (2018) Transgelin induces dysfunction of fetal endothelial colony-forming cells from gestational diabetic pregnancies. Am J Physiol Cell Physiol 315:502–515. https://doi.org/10.1152/ajpcell.00137.2018.-FetalCrossRef

64.

Dulak J, Józkowicz A (2005) Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy. Curr Cancer Drug Targets 5:579–594. https://doi.org/10.2174/156800905774932824CrossRefPubMedPubMedCentral

65.

Xiao Y, Li Y, Han J et al (2012) Transgelin 2 participates in lovastatin-induced anti-angiogenic effects in endothelial cells through a phosphorylated myosin light chain-related mechanism. PLoS ONE 7:e46510. https://doi.org/10.1371/journal.pone.0046510CrossRefPubMedPubMedCentral

Titel: FOXO1 promotes endothelial cell elongation and angiogenesis by up-regulating the phosphorylation of myosin light chain 2
verfasst von: Kiyomi Tsuji-Tamura
Minetaro Ogawa
Publikationsdatum: 24.07.2023
Verlag: Springer Netherlands
Erschienen in: Angiogenesis / Ausgabe 4/2023
Print ISSN: 0969-6970
Elektronische ISSN: 1573-7209
DOI: https://doi.org/10.1007/s10456-023-09884-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

FOXO1 promotes endothelial cell elongation and angiogenesis by up-regulating the phosphorylation of myosin light chain 2

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Blutdrucksenkung könnte Uterusmyome verhindern

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

Update Innere Medizin

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2023

Correction to: BI1 is associated with microvascular protection in cardiac ischemia reperfusion injury via repressing Syk-Nox2-Drp1-mitochondrial fission pathways

Effect of erythrophagocytosis-induced ferroptosis during angiogenesis in atherosclerotic plaques

Embracing Imatinib: a novel approach to safeguarding the endothelial barrier in patients with COVID-19

Correction: Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic inflammation

The dynamics of the endothelial glycocalyx: a rare snapshot by electron microscopy

Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic inflammation

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Blutdrucksenkung könnte Uterusmyome verhindern

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

Update Innere Medizin